1. Home
  2. NUCL vs PRQR Comparison

NUCL vs PRQR Comparison

Compare NUCL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NUCL

Eagle Nuclear Energy Corp. Common stock

N/A

Current Price

$6.05

Market Cap

308.2M

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.57

Market Cap

262.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUCL
PRQR
Founded
2023
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.2M
262.5M
IPO Year
2026
2014

Fundamental Metrics

Financial Performance
Metric
NUCL
PRQR
Price
$6.05
$1.57
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $7.78
AVG Volume (30 Days)
213.9K
★ 636.7K
Earning Date
10-20-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.25
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.63
$1.33
52 Week High
$14.22
$3.10

Technical Indicators

Market Signals
Indicator
NUCL
PRQR
Relative Strength Index (RSI) 37.90 29.74
Support Level $5.75 $1.37
Resistance Level $6.45 $1.58
Average True Range (ATR) 0.31 0.08
MACD 0.01 -0.01
Stochastic Oscillator 27.50 9.46

Price Performance

Historical Comparison
NUCL
PRQR

About NUCL Eagle Nuclear Energy Corp. Common stock

Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds the rights to the mineable, measured and indicated uranium deposit in the United States, referred to as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated 37.73 million pounds of near-surface uranium and the adjacent Cordex Zone Eagle's SMR technology. Eagle's mission is to supply uranium to the growing nuclear energy industry and play a role in the global transition to clean, reliable, and affordable energy.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: